Research Progress of Shenling Baizhu Powder in the Treatment of Type 2 Diabetes Mellitus Combined with Obesity
DOI:
https://doi.org/10.53469/jcmp.2024.06(11).22Keywords:
Type 2 diabetes mellitus, Shenling Baizhu Powder, Obesity, Research progressAbstract
In recent years, type 2 diabetes mellitus (T2DM) is a chronic metabolic disease whose prevalence is increasing year by year [1]. T2DM is characterized by insulin resistance and impaired pancreatic β-cell function, which leads to elevated blood glucose levels. Obesity is one of the important risk factors for T2DM, and the two often coexist and influence each other, increasing the complexity of chronic disease management. Modern clinical studies [2-3] have confirmed in a large number of practices that traditional Chinese medicines (TCM) have definite efficacy in the treatment of type 2 diabetes mellitus combined with obesity, especially spleen-strengthening and dampness-dispelling TCM compound prescriptions such as Shenling Baizhu Powder, Zhi Zhu Tang, and San Ren Tang, etc., which have been proven in clinics to not only reduce the patient's body mass index (BMI), but also assist in controlling blood glucose, and delaying or reversing the disease progression of type 2 diabetes mellitus [4-5]. In this paper, by searching the relevant literature in recent years, we reviewed the recent research on the treatment of type 2 diabetes mellitus combined with obesity by Shenling Baizhu Powder to provide a basis for further in-depth study and rational use of medication.
References
Wei Junping. Current status and development trend of clinical research on the prevention and treatment of diabetes mellitus by combining Chinese and Western medicine[J]. Chinese Journal of Integrated Traditional and Western Medicine, 2021, 41(01):13-15.
Zhou Q, Chang B, Chen XY, et al. Chinese herbal medicine for obesity: a randomized, double-blinded, multicenter, prospective trial. Am J Chin Med. 2014;42 (6):1345-1356.
Yao Q, Li S, Cheng X, et al. Yin Zhi Huang, a traditional Chinese herbal formula, ameliorates diet-induced obesity and hepatic steatosis by activating the AMPK/SREBP-1 and the AMPK/ACC/CPT1A pathways. Ann Transl Med. 2020;8 (5):231.
Zhang Y, Tang K, Deng Y, et al. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. Biomed Pharmacother. 2018;102:1025-1036.
Tao Lili, Wang Yinhui, Chen Xiaoping, et al. Effects of acupoint burrowing combined with spleen-strengthening and phlegm-expelling traditional Chinese medicine on glucose and lipid metabolism in obese patients with polycystic ovary syndrome[J]. Journal of Traditional Chinese Medicine, 2010, 51(03):239-242.
537 million adults worldwide have diabetes, 140 million in China[N]. Physician's Weekly, 2021-12-09(B03).
Chinese Medical Association Diabetes Branch. Guidelines for the Prevention and Treatment of Type 2 Diabetes Mellitus in China (2020 edition) [J]. International Journal of Endocrinology and Metabolism, 2021, 41(05):482-548
Chen Weiwei, Gao Runlin, Liu Lisheng, et al. Summary of the China Cardiovascular Disease Report 2017[J]. Chinese Circulation Journal, 2018, 33(01):1-8.
Laakso M. Biomarkers for type 2 diabetes. Mol Metab. 2019;27S:S139-S146.
Volaco A, Cavalcanti AM, Filho RP, et al. Socioeconomic Status: The Missing Link Between Obesity and Diabetes Mellitus?. Curr Diabetes Rev. 2018;14 (4):321-326.
Rubio-Almanza M, Cámara-Gómez R, Merino-Torres JF. Obesity and type 2 diabetes: Also linked in therapeutic options. Endocrinol Diabetes Nutr (Engl Ed). 2019;66 (3):140-149.
Yang Yafeng, Wang Ping, Wang Li, et al. Study on the correlation between insulin resistance and visceral fat area in male patients with type 2 diabetes mellitus combined with abdominal obesity[J]. Shaanxi Medical Journal, 2020, 49(06):717-719.
Liu Cong, Cao Junying, et al. Study on the diagnostic value of backscatter integral for early diabetic retinopathy[J]. Journal of Trauma and Critical Care Medicine, 2019, 7(05):290-291+294.
Li Lei, Zhang Yanli, Chen Meiqing, et al. Analysis of SLBZS chemical composition and incoming blood components by UPLC-Q-TOF-MS/MS technique[J]. Traditional Chinese Drug Research & Clinical Pharmacology, 2024, 35(04):553-562.
Lu Guangying, Xing Xunyan, Wang Jiayun, et al. Progress in the study of classic formula SLBZS and predictive analysis of quality markers[J]. Chinese Journal of Traditional Chinese Medicine, 2022, 47(19):5171-5181.
Cao Shuli, Zhao Chunjie, Cai Lixia, et al. Simultaneous determination of psoralen, isopsoralen, atractylenolide III and isoeuropregnanolide in SLBZS by UPLC method[J]. Journal of Shenyang Pharmaceutical University, 2018, 35(07):568-573.
Wang Yue, Wang Yaling, Zou Jing et al. Determination of licorice flavonoids and ginsenosides in SLBZS and antioxidant assay[J]. Contemporary Chemical, 2020, 49(07):1301-1304.
Li Jinglin, Wang Mei, Shi Yajun, et al. Fingerprinting and multi-component quality study of SLBZS based on UPLC method[J]. Chinese Pharmacist Magazine, 2019, 22(02):214-218.
Bao Rong. Intervention effect of SLBZS on gastrointestinal dysfunction and malnutrition - microinflammatory state in patients with spleen deficiency and stasis in continuous ambulatory peritoneal dialysis[D]. Anhui University of Chinese Medicine, 2020.
Peng Ying, Xi Shengyan, Wang Yanhui, et al. Effect of SLBZS on tumor apoptosis-related factors in H22 hepatocellular carcinoma transplanted tumor-bearing mice after chemotherapy[J]. Chinese Journal of Traditional Chinese Medicine, 2017, 32(07):2909-2913.
Hao Lin, Yan Ling. Clinical study of SLBZS combined with pioglitazone in the treatment of type 2 diabetes mellitus with spleen deficiency and dampness[J]. Modern Drugs and Clinical, 2024, 39(10):2640-2644.
Zhang LJ, Zhan LB, Hang TY, et al. Shenling Baizhu Powder alleviates chronic inflammation to prevent type 2 diabetes of ZDF rats via intestinal flora[J]. Zhongguo Zhong Yao Za Zhi. 2022;47 (4):988-1000.
Wang Xiangyu. Effect of SLBZS plus or minus combined with Insulin Aspart 30 on blood glucose and lipid levels in patients with type 2 diabetes mellitus[J]. Journal of Chronic Disease, 2024, 25(04):549-552.
Niu Chengmiao, Liang Tingli, Yin Yongkai, et al. Molecular Mechanism Study and Animal Experimental Validation of SLBZS to Ameliorate Adipose Tissue Inflammation in Childhood Obesity Based on Network Pharmacology Exploration[J/OL]. China Journal of Traditional Chinese Medicine Information, 1-8[2024-11-07].
Jin Xiaoqin, Liu Bin, Liu Haoyuan, et al. Exploring the mechanism of action of SLBZS in the treatment of obesity based on intestinal flora[J]. Acta Chinese Medicine, 2023, 38(08):1732-1738.
Wang Xiange, Liu Aihua, Guo Geli, et al. Effect of SLBZS-assisted Western medicine on glycemic control, body mass index, and pancreatic β-cell function in obese patients with type 2 diabetes mellitus[J]. Acta Academiae Medicine Weifang, 2023, 45(06):438-441.
Luo Jintong, Zhang Lijing, Zhan Libin, et al. Role of SLBZS on pancreatic β-cell dedifferentiation in obese type 2 diabetic ZDF rats[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2023, 38(12): 6034-6039.
Zhang Shuqin, Li Yanjie, Qin Hewei, et al. Exploring the mechanism of action of SLBZS to improve obese type 2 diabetic mice based on AMPK signaling pathway[J]. Journal of Chinese Medicinal Materials, 2022, 45(11):2737-2742.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Shiqi Liang, Yijiang Liu, Xinyue Fan, Wen Xie, Lu Shen
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
